compounding glp 1 GLP-1 is still in limbo. Will the FDA leave it for the next administration? Compounded GLP-1 – Hayden's Pharmacy

Tirzepatide for T2D obesity SURMOUNT-2, weight -12.8/-14.7% at 10/15 mg, attenuated about 6-7 points vs non-diabetic obesity: Garvey Lancet 2023

Gastrointestinal Research Because of its origin in gastric tissue, BPC-157 is evaluated for potential effects on: Gastrointestinal mucosal protection Ulcer models Intestinal barrier support Inflammatory modulation in GI tissue 4

Figure 11: Platelets and tumor cells modulate the immune response and increase the production of proinflammatory proteins (like cytokines) and reactive oxygen species [inflammation] (1 and 2)

( ) ( ) ( ) Registered Industrial Designs 8614071868 Standard Products High Quality Products Patent Certificate